243 related articles for article (PubMed ID: 22963114)
1. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study.
Sweetland S; Beral V; Balkwill A; Liu B; Benson VS; Canonico M; Green J; Reeves GK;
J Thromb Haemost; 2012 Nov; 10(11):2277-86. PubMed ID: 22963114
[TBL] [Abstract][Full Text] [Related]
2. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
[TBL] [Abstract][Full Text] [Related]
3. Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis.
Scarabin PY
Climacteric; 2018 Aug; 21(4):341-345. PubMed ID: 29570359
[TBL] [Abstract][Full Text] [Related]
4. Hormone therapy and venous thromboembolism among postmenopausal women.
Scarabin PY
Front Horm Res; 2014; 43():21-32. PubMed ID: 24943295
[TBL] [Abstract][Full Text] [Related]
5. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
[TBL] [Abstract][Full Text] [Related]
6. The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Roach RE; Lijfering WM; Helmerhorst FM; Cannegieter SC; Rosendaal FR; van Hylckama Vlieg A
J Thromb Haemost; 2013 Jan; 11(1):124-31. PubMed ID: 23136837
[TBL] [Abstract][Full Text] [Related]
7. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
Canonico M
Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
[TBL] [Abstract][Full Text] [Related]
8. Oral postmenopausal hormone therapy and genetic risk on venous thromboembolism: gene-hormone interaction results from a large prospective cohort study.
Kim J; Bhupathiraju SN; Harrington LB; Hagan KA; Lindström S; Manson JE; Kraft P; Kabrhel C
Menopause; 2022 Jan; 29(3):293-303. PubMed ID: 35013060
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
Beral V; Reeves G; Bull D; Green J;
J Natl Cancer Inst; 2011 Feb; 103(4):296-305. PubMed ID: 21278356
[TBL] [Abstract][Full Text] [Related]
10. Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism.
Renoux C; Dell'Aniello S; Brenner B; Suissa S
Pharmacoepidemiol Drug Saf; 2017 May; 26(5):554-560. PubMed ID: 28326633
[TBL] [Abstract][Full Text] [Related]
11. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
12. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
Archer DF; Oger E
Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
[TBL] [Abstract][Full Text] [Related]
14. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
Olié V; Plu-Bureau G; Conard J; Horellou MH; Canonico M; Scarabin PY
Menopause; 2011 May; 18(5):488-93. PubMed ID: 21178641
[TBL] [Abstract][Full Text] [Related]
15. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
[TBL] [Abstract][Full Text] [Related]
16. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.
Grady D; Wenger NK; Herrington D; Khan S; Furberg C; Hunninghake D; Vittinghoff E; Hulley S
Ann Intern Med; 2000 May; 132(9):689-96. PubMed ID: 10787361
[TBL] [Abstract][Full Text] [Related]
18. Different menopausal hormone regimens and risk of breast cancer.
Brusselaers N; Tamimi RM; Konings P; Rosner B; Adami HO; Lagergren J
Ann Oncol; 2018 Aug; 29(8):1771-1776. PubMed ID: 29917061
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary embolism in menopausal hormone therapy: a population-based register study.
Sundell M; Spetz Holm AC; Fredrikson M; Hammar M; Hoffmann M; Brynhildsen J
Climacteric; 2022 Dec; 25(6):615-621. PubMed ID: 36218141
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
Canonico M; Fournier A; Carcaillon L; Olié V; Plu-Bureau G; Oger E; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Scarabin PY
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):340-5. PubMed ID: 19834106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
